Pacific Biosciences
PACB
#6557
Rank
โ‚ฌ0.61 B
Marketcap
2,05ย โ‚ฌ
Share price
-5.16%
Change (1 day)
6.84%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2025 (TTM): โ‚ฌ0.13 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.13 Billion. In 2024 the company made a revenue of โ‚ฌ0.14 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.13 B-6.4%
2024 โ‚ฌ0.14 B-18.41%
2023 โ‚ฌ0.18 B51.65%
2022 โ‚ฌ0.11 B3.79%
2021 โ‚ฌ0.11 B79.67%
2020 โ‚ฌ64.14 M-20.95%
2019 โ‚ฌ81.13 M18.05%
2018 โ‚ฌ68.72 M-11.77%
2017 โ‚ฌ77.89 M-9.67%
2016 โ‚ฌ86.24 M1.63%
2015 โ‚ฌ84.85 M70.32%
2014 โ‚ฌ49.82 M144.16%
2013 โ‚ฌ20.4 M3.88%
2012 โ‚ฌ19.64 M-24.67%
2011 โ‚ฌ26.07 M1971.9%
2010 โ‚ฌ1.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
โ‚ฌ3.68 B 2,673.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚ฌ0.13 B 5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ37.74 B 28,329.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ37.56 B 28,192.06%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ2.88 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA